Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for InvestorsTip Ranks·2 days ago, 01:01 AMCOCH+0.17%
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSMarket Beat·Aug 10 at 07:56 AMCOCH+0.17%
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q SummaryTradingView·Aug 10 at 07:41 AMCOCH+0.17%
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones | COCH Stock NewsStockTitan·Aug 9 at 11:00 PMCOCH+0.17%
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky IndustrialMorningStar·Aug 1 at 10:38 AMDVLT+1.94%BSIN-2.52%
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)MorningStar·Jul 18 at 12:03 PMBSIN-2.52%COCH+0.17%
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Resultsbenzinga_article·Jul 14 at 08:01 AMCOCH+0.17%
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant | COCH Stock NewsStockTitan·Jul 14 at 12:17 AMCOCH+0.17%
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device | COCH Stock NewsStockTitan·Jun 29 at 11:30 PMCOCH+0.17%
